Supplement Lobbies Support Incentives But First Want More Enforcement

By David Roza / April 18, 2019 at 1:24 PM
The heads of two major dietary supplement lobbies support establishing incentives for the dietary supplement industry, including the possibility of exclusivity, but they are adamant such incentives should not mirror exclusivity as it exists in the prescription drug space. They add, however, that FDA should first pursue stricture enforcement of new dietary ingredient (NDI) notification requirements from dietary supplement companies to help ensure product safety. Former FDA Commissioner Scott Gottlieb raised the idea of exclusivity for dietary supplements in February,...


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.